MINOCA ASOCIADO A SDRA SEVERO POR COVID-19, A PROPÓSITO DE UN CASO

Abstract

Coronavirus disease 2019 (COVID 19) can cause a wide range of cardiovascular diseases. The universal definition of myocardial infarction (MI) differentiates between type 1 and type 2 MI. Type 1 generally refers to acute atherothrombotic disease that is precipitated by rupture of the atherosclerotic plaque. Type 2 occurs as a result of an imbalance in oxygen supply in the context of higher than usual demand, so MI with non-obstructive coronary artery (MINOCA) is, in fact, a type 2 MI due to complications of COVID-19. MINOCA is defined as having a stenosis of less than 50% or no stenosis on coronary angiography in a patient diagnosed with myocardial infarction. because your predisposition thrombogenic in COVID-19, the diagnosis of síndrome rare MINOCA once you think about the patients with heart attack myocardial con elevation of the ST segment is the electrocardiogram. Among the multiple causes of MINOCA there are different groups of coronary reactivity alterations: epicardial and microvascular, including coronary spasm, atherosclerotic plaque disruption and coronary dissection, takotsubo disease, myocarditis and coronary thromboembolism. The treatment of MINOCA is based on limited evidence and there are no prospective, randomized, controlled trials. Antiplatelet drugs, beta blockers, clopidogrel, angiotensin converting enzyme inhibitors should be considered based on the underlying mechanism of MINOCA in each individual. Being a pathology without etiology and pathogenesis not fully defined, therefore, a correlation is made of the information obtained through the clinical case with the current bibliography in terms of epidemiology, etiology, pathophysiology and optimal treatment to be carried out in this type. of patients